Literature DB >> 2559749

A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot.

T Huet1, M C Dazza, F Brun-Vézinet, G E Roelants, S Wain-Hobson.   

Abstract

In central equatorial Africa the frequency of uninterpretable or atypical Western blots (WB)--ie. antibodies to gag proteins only--can represent up to 50% of enzyme-linked immunosorbent assay (ELISA)-positive samples. To date the significance of such serology remains unknown. Nevertheless, an unusual HIV-1 strain has been isolated from the blood of a healthy Gabonese individual who presented an atypical WB. This virus, identified as isolated HIV-1OYl, grew to low titres of reverse transcriptase activity (less than 50,000 cpm/ml) and was not obviously cytopathic. Radioimmunoprecipitation and peptide ELISA studies indicated that the lack of env-specific reactivity was probably due to the absence of antibodies to the viral glycoproteins, rather than the virus encoding a highly divergent envelope protein. Molecular cloning and sequencing of the provirus proved it to be a string of HIV-1 which was genetically closer to European and North American than to African strains. Furthermore the envelope protein sequence contained all the features of a typical HIV-1 env gene. However, the tat gene derived from the proviral clone was functionally defective. Site-directed mutagenesis of this gene showed that this was due to the substitution of an essential cysteine residue for a serine. Polymerase chain reaction amplification of the tat gene, as well as parts of the gag and env gene sequences of HIV-1OYl, showed that essentially all of the proviruses were defective. These data emphasize the need to view HIV isolates as populations of distinct genomes capable of complementing each other.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559749     DOI: 10.1097/00002030-198911000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  30 in total

1.  HIV-1 in Ethiopia: phylogenetic divergence from other HIV-1 strains.

Authors:  S Ayehunie; B Johansson; M Salminen; P Leinikki; A Sönnerborg; D W Zewdie; S Britton; O Strannegård
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

2.  Reactivity patterns and infection status of serum samples with indeterminate Western immunoblot tests for antibody to human immunodeficiency virus type 1.

Authors:  E Ramirez; P Uribe; D Escanilla; G Sanchez; R T Espejo
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 3.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

4.  A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade.

Authors:  Sonia Mediouni; Jennifer D Watkins; Michel Pierres; Angélique Bole; Erwann P Loret; Gilbert Baillat
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

5.  Identification of a highly conserved surface on Tat variants.

Authors:  Sonia Mediouni; Albert Darque; Isabelle Ravaux; Gilbert Baillat; Christian Devaux; Erwann P Loret
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

6.  Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes.

Authors:  J P Vartanian; A Meyerhans; B Asjö; S Wain-Hobson
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Comparative humoral responses to human immunodeficiency virus type 1-p24gag linear B-cell epitopes among individuals showing atypical western immunoblotting reactions and implications for diagnosis.

Authors:  J C Lallement; J P Vendrell; P Corbeau; J Ducos; M Segondy; A Escande; V Robert-Hebmann; F Jean; J Reynes; A Serre
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses.

Authors:  E G Shpaer; J I Mullins
Journal:  J Mol Evol       Date:  1993-07       Impact factor: 2.395

9.  Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.

Authors:  Y Luo; S J Madore; T G Parslow; B R Cullen; B M Peterlin
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Comparing models of evolution for ordered and disordered proteins.

Authors:  Celeste J Brown; Audra K Johnson; Gary W Daughdrill
Journal:  Mol Biol Evol       Date:  2009-11-18       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.